Short Description

The association between the CYP3A5 genotype and tacrolimus pharmacokinetics is well established, and patients expressing functional CYP3A5 (carriers of the CYP3A5*1 allele extensive metabolizer), require approximately double the starting drug dose. Carriers of CYP3A5*3/*3 or poor metabolizer require higher doses.

PreTest Information

No special preparation required

Detail Description

Tacrolimus Genotyping (CYP3A5) Test: Cost, Symptoms, and Diagnosis

DNA Labs India provides Tacrolimus Genotyping (CYP3A5) Test, which is a genetic test that helps in determining the patient's ability to metabolize Tacrolimus, a commonly prescribed immunosuppressive drug. This test is essential for patients who have undergone organ transplantation, as Tacrolimus is used to prevent organ rejection.

Cost of Tacrolimus Genotyping (CYP3A5) Test

The cost of Tacrolimus Genotyping (CYP3A5) Test at DNA Labs India is INR 7000. The test is affordable and provides accurate results.

Symptoms of Tacrolimus Toxicity

Tacrolimus toxicity occurs when the patient's body is unable to metabolize the drug effectively. The symptoms of Tacrolimus toxicity include:

• Nausea and vomiting
• Diarrhea
• Abdominal pain
• Headache
• Tremors
• High blood pressure
• Changes in vision
• Swollen ankles

If you experience any of these symptoms, you should contact your doctor immediately.

Diagnosis of Tacrolimus Toxicity

The diagnosis of Tacrolimus toxicity is based on a physical examination and blood tests. If the doctor suspects Tacrolimus toxicity, they may order a Tacrolimus Genotyping (CYP3A5) Test to determine the patient's ability to metabolize the drug effectively.

Conclusion

Tacrolimus Genotyping (CYP3A5) Test is an essential genetic test for patients who have undergone organ transplantation. It helps in determining the patient's ability to metabolize Tacrolimus effectively and prevent Tacrolimus toxicity. The test is affordable and provides accurate results. If you experience any symptoms of Tacrolimus toxicity, you should contact your doctor immediately.

For more information on Tacrolimus Genotyping (CYP3A5) Test, visit DNA Labs India today!

The association between the CYP3A5 genotype and tacrolimus pharmacokinetics is well established, and patients expressing functional CYP3A5 (carriers of the CYP3A5*1 allele; extensive metabolizer), require approximately double the starting drug dose. Carriers of CYP3A5*3/*3 or poor metabolizer require higher doses.